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Purpose: To identify the genomic location of previously uncharacterized canine retina-expressed expressed sequence
tags (ESTs), and thus identify potential candidate genes for heritable retinal disorders.
Methods: A set of over 500 retinal canine ESTs were mapped onto the canine genome using the RHDF5000–2 radiation
hybrid (RH) panel, and the resulting map positions were compared to their respective localization in the CanFam2 assembly
of the canine genome sequence.
Results: Unique map positions could be assigned for 99% of the mapped clones, of which only 29% showed significant
homology to known RefSeq sequences. A comparison between RH map and sequence assembly indicated some areas of
discrepancy. Retinal expressed genes were not concentrated in particular areas of the canine genome, and also were located
on the canine Y chromosome (CFAY). Several of the EST clones were located within areas of conserved synteny to human
retinal disease loci.
Conclusions: RH mapping of canine retinal ESTs provides insight into the location of potential candidate genes for
hereditary retinal disorders, and, by comparison with the assembled canine genome sequence, highlights inconsistencies
with the current assembly. Regions of conserved synteny between the canine and the human genomes allow this
information to be extrapolated to identify potential positional candidate genes for mapped human retinal disorders.
Furthermore, these ESTs can help identify novel or uncharacterized genes of significance for better understanding of
retinal morphology, physiology, and pathology.
Heritable disorders of the retina often inflict devastating
harm on the lives of affected individuals and their families.
Progress in identifying the genetic causes of these diseases has
accelerated  in  recent  years,  but  still  presents  serious
challenges; in many cases nothing is known of the genetic loci
involved. Currently, for diseases where the genetic locus has
been mapped, close to 30% have not yet had the responsible
gene or mutation identified (RetNet). A limiting factor to this
progress is an incomplete catalog of the genes expressed in
the retina [1].
Animals also suffer from heritable retinal disorders. This
is a source of concern when it afflicts companion or working
animals and yet affected animals can be a valuable resource
when used as models of human disorders. The broadly similar
features of retinitis pigmentosa (RP) in human families and
progressive retinal atrophy (PRA) in dogs have prompted
extensive, productive, and mutually beneficial comparative
studies of these homologous disorders [2].
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Expressed  sequence  tags  (ESTs)  have  played  an
extremely powerful role in the identification and cataloguing
of new and tissue-specific genes [3]. The combination of EST
discovery  with  radiation  hybrid  (RH)  mapping  has  been
invaluable to the development, assembly, and annotation of
the human gene map [4], a critical first step to an assessment
of individual disease loci. However, identification of disease-
causing genes within mapped loci that typically have 0.5–10
cM intervals is problematic as the human genome can harbor
5–300 potential candidate genes for a single disorder in these
intervals [5]. Comparative genomics is often used to further
refine these results. This has recognized limitations if the
identification of homolog genes is based only on the alignment
of  cDNA  clones,  which  may  not  always  cover  areas  of
sufficient conservation between the compared species [6].
Previous  efforts  in  the  definition  of  the  canine  genome
included combinations of gene identification and mapping
[7], which was further improved by the release of a 7.6x draft
sequence (Genome) [8]. Hence, the dog constitutes a unique
resource for disease genetics.
A  recently  developed,  normalized,  canine  retina-
expressed sequence tag library [9], supported by an online
database (DOG EST or DOG EST Project), currently catalogs
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9277,047 individual clones comprising more than 4,000 unique
transcripts. About two-thirds of the clones in this library were
identified as orthologous to annotated RefSeq sequences, and,
of  those,  41%  corresponded,  by  sequence  identity,  to
previously annotated canine cDNA entries. However, 1,418
of the transcripts remain to be annotated with certainty. In the
present study, a subset of 553 clones was mapped using the
well established canine/hamster hybrid panel RHDF5000–2 [10,
11] to locate the corresponding retinal genes within the dog
genome and, by comparative genomics, to infer their location
in human.
Comparison of EST map positions obtained by RH and
sequence  mapping  overcomes  the  disadvantages  and
limitations of each method alone, and offers the most reliable
chromosomal locations for each EST. Such an integrated map
provides substantial information on potential new candidate
genes for heritable retinal disorders.
METHODS
Clone identification and primer design: A set of 1,418 ESTs
could not be identified with a high level of confidence by
alignment with RefSeq genes or previously mapped canine
cDNAs  from  the  previously  reported  canine  retinal  EST
library [9]. This particular set was then selected for mapping
on the RH panel. A total of 35 EST sequences had to be
excluded  from  primer  design  based  on  their  respective
sequences. Primer pairs for the remaining EST sequences
were  obtained  in  one  of  two  ways.  227  were  manually
designed using the primer select option of the Lasergene™
software (Dnastar, Inc., Madison, WI). 1,156 were selected
automatically  using  the  batch  primer  design  feature  of
GeneLooper™ (GeneHarbor, Inc., Rockville, MA) with an
oligo Tm of 68 °C, and allowing primers within 100–150 bp
of either end of the available sequence. From the latter 1,156
primer pairs, those resulting in PCR products smaller than 100
bp were excluded, and primers were sorted for increasing
penalty scores assigned by the software; this yielded 920
primer pairs that were accepted for analysis. Together with
the initial 227 pairs, a total of 1,147 EST sequences were thus
assigned to the mapping project (Appendix 1).
RH amplification and data collection: Each PCR product was
amplified  under  standard  conditions  using  25  ng  DNA
template, 1 mM MgCl2, 0.2 mM of each dNTP, 0.2 µM of
each respective primer, and 0.5 U Taq polymerase.
Following an initial denaturation step at 94 °C for 2 min,
35 cycles were performed at 94 °C for 15 s, 52 °C, 55 °C,
58 °C, or 62 °C, respectively (Appendix 1) for 15 s, and 72 °C
for 40 s. This was then followed by a final extension at 72 °C
for 5 min. All PCR products were visualized on 2% agarose
gels.
In the first step, primer pairs were used to amplify canine
genomic DNA. Those that failed to amplify a single product
of the expected size were not continued in the analysis (result
F,  Appendix  1).  Primers  that  reliably  amplified  canine
genomic DNA (result D, Appendix 1) were then tested for
differential amplification of dog and hamster DNA. Those that
yielded either no detectable hamster amplicon or a product
significantly different in size from the canine amplicon (result
RH and M, Appendix 1) were subsequently used to amplify
all 118 cell lines of the canine and hamster hybrid panel
RHDF5000–2 together with previously used hamster and dog
DNA as controls. PCR results were manually transferred into
a  computer  file  registering  presence  or  absence  of
amplification for each cell line.
Mapping  algorithm:  The  data  were  analyzed  against  the
previously  published  RHDF5000–2  map  [12].  ESTs  were
assigned to chromosomes, based on the chromosomal location
of the closest linked previously mapped RH marker [12],
using  the  MultiMap  [13]  best-two-points  function.
Chromosomes for which marker density was too low to yield
a  consistent  whole-chromosome  linkage  group  were
partitioned into blocks, and individual maps were created of
each block. A framework map of each block was first created
using MultiMap at a logarithm of the odds (LOD) of 3 or more
and  then  filled  in  at  continually  lowering  LOD  scores.
Chromosomes were oriented using markers previously placed
on meiotic and RH maps [12].
BLAST results and graphic display: Genomic localization for
each  EST  was  assigned  for  the  current  canine  genome
sequence (Genome Gateway; CanFam2, May 2005) using
BLASTN (cutoff value E≤1e−100). The genomic position thus
identified for each EST and selected anchor markers were
displayed in a graph relative to the size of the respective
chromosome. This was done using software developed at the
Cornell  University  Computational  Biology  Service  Unit
(available from the authors upon request). RetNet (RetNet;
status January 2009) was searched to identify the map location
of hereditary retinal disorders on the human genome. For all
such human disease loci mapped to intervals less than 25 Mb,
the homologous region of the canine genome was established
using BioMart, and refined according to the UCSC genome
browser multiple alignments, disregarding alignments of less
than 20 kb in length (Appendix 2).
RESULTS
Performance of retinal ESTs on the RHDF5000–2 panel: From
the initial set of 1,418 ESTs with no detected homology to
previously known sequences, amplification was attempted for
a subset of 1,147 markers. Of these, 998 (87%) amplified a
unique  PCR  product  from  canine  genomic  DNA  without
optimization,  and  711  (62%)  amplified  a  consistent  and
distinctive product from the RHDF5000–2 panel cell lines (Table
1).  Roughly  half  of  the  ESTs  tested  could  be  scored
satisfactorily for each of the 118 cell lines (Figure 1A). The
overall presence of each EST marker on the panel (Figure 1B)
was  similar  to  previously  published  results  (e.g.,  average
retention frequency 22% in [12]). Furthermore, linkage to at
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found; this was supported by most two-point LOD scores
higher than 10 (Figure 1C, Appendix 3).
Distribution  of  newly  mapped  retinal  ESTs  in  the  canine
genome: Of 553 ESTs linked to known markers, 501 could be
mapped to unique positions, ranging from 3 to 34 ESTs per
chromosome (Table 2, Appendix 4). An additional 48 ESTs
were linked, but not uniquely placed on the RH map. The
remaining four EST loci collapsed with one of the other loci
(Appendix 3) and were not counted as separate transcripts,
reducing the total number of individually displayed loci to
549. The average number of ESTs per Mb mapped on the RH
panel was calculated for each chromosome. These data were
then compared to results obtained for all EST clones contained
in  the  library  (Table  2).  With  respect  to  the  size  of  the
chromosomes, relatively fewer clones were represented on the
RH map for Canis familiaris chromosome (CFA) 19, CFA32,
and CFAX; clones  represented  in  the  complete  library
appeared  to  be   evenly  distributed  throughout  the  genome
with the exception of CFA19, which was synteny to  portions
of  human  chromosomes  2  and  4  [10].  It  remains  to be
elucidated  whether  this  is   due  to  underrepresentation  of
retinal clones on CFA19 or, more likely, poorer annotation of
this chromosome.
Comparison  of  RH  and  sequence  maps:  For  each
chromosome, the linkage groups comprising all RH mapped
retinal  ESTs  were  aligned  to  the  current  canine  genome
sequence (Appendix 5). Apparent micro-rearrangements of
markers among the maps were the most common discrepancy
observed, particularly where markers could not be positioned
on  the  RH  map  with  high  confidence.  This  is  a  familiar
problem for markers located toward the end of a linkage
group, e.g., CFA6 and CFA10 (Appendix 5).
Fourteen markers diverged in placement between the RH
and sequence maps. Eight of these yielded best two-point
linkage to a single chromosome, but could not be mapped in
a  unique  position  on  the  RH  map  (Appendix  5;  e.g.,
DR010005B10H04 on CFA22). Therefore, correct genomic
position  of  these  ESTs  should  be  assumed  based  on  the
sequence alignment, since it is the better supported method
for these clones. The other six ESTs (DR01007A10C09 and
DR010025B10A10 on CFA4, DR010009A20D03 on CFA6,
DR010013A10E04 on CFA7, DR010027B10D03 on CFA17,
and  DR010015B20A07  on  CFA19)  were  in  complete
disagreement with the RH map and the sequence assemblies
(Appendix  5;  no  placements  on  D).  Without  additional
information, correct genomic location of these ESTs cannot
be determined.
Indication of genome sequence alignment problems: A subset
of ESTs proved difficult to align to a unique area of the
sequence  assembly.  Despite  the  high  cut-off  value  (E≤1e
−100),  22  markers  that  were  RH  mapped  to  16  different
chromosomes showed significant sequence alignment to more
than one chromosome. In each case, the multiple alignments
included  the  chromosome  assigned  by  the  RH  map.  A
consensus chromosomal position for these markers was thus
based on the RH map (Appendix 5, e.g., DR010017A21D11
on CFA14, DR01005A20E07 on CFA15, placement on C, D,
and E).
In  addition  to  the  aforementioned  issues  in  placing
individual  markers,  some  genomic  regions  revealed
consistent  complications.  Several  markers  RH  mapped  to
CFA17 did not align to the same chromosome in the canine
genome  sequence  draft;  DR010027B10D03  mapped  to
CFA3,  while  DR010006A10A08,  DR010025A10C12,
DR010010B20B05, and DR010024A10E04 yielded multiple
hits  on  CFA17,  in  addition  to  several  alignments  against
alignments  against  a  part  of  the  sequence  assembly  not
assigned  to  chromosomes  (chrUN).  Similarly,  marker
DR010026A20B10 on CFA11 aligned to multiple genomic
locations. It is also worth mentioning that the three ESTs RH
mapped to CFAY have significant sequence homology to
locations on CFAX in the genome sequence assemblies.
TABLE 1. EST LOCI RETAINED AT EACH EXPERIMENTAL STEP.
EST loci Number Percent
Tested 1,147 100.0
Amplified on dog DNA 998 87.0
Amplified satisfactorily on the RH5000–2 panel 711 62.0
Readable scores for all cell lines 555 48.4
Linked to at least one other marker 553 48.2
Mapped in unique position 501 43.7
To assess quality and efficiency of primer design, all primers were first amplified on dog DNA. Subsequently, working primer
pairs were amplified on the RH panel, which proved to be the least efficient step. Of those satisfactorily amplifying on the panel,
almost 80% could be scored in all cell lines, and only two of the scored ESTs did not provide sufficient linkage to at least on
other marker. Finally, 90% of all linked markers were assigned to unique positions in the chromosome, thus yielding results for
44% of all tested primers without further optimization.
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929Figure  1.  Quality  control  for  retinal
clones on the RHDF5000–2 panel. A total
of  555  retinal  clones  were  amplified
from  118  cell  lines  representing  the
RHDF5000–2 panel. For each locus, we
assessed both, the overall number of cell
lines  that  could unambiguously  be
scored,  and  the  number  of  cell  lines
amplifying  the  respective  EST,  for
quality. Half of the loci were scored in
each individual line with the balance of
loci missing only few scores (A). The
respective retention frequency resulting
from amplification scores, on average,
was 0.22 and showed a distribution that
is similar to previously published data
[12]  using  this  panel  (B).  The  good
quality  performance  of  EST
amplification  resulted  in  highly
supported  linkage  to  known  markers
(C) with most of the LOD scores above
10.
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930Identification of potential candidate genes for human retinal
disorders: The homologous canine genome locations for 28
mapped human retinal disease loci (RetNet), for which disease
causing genes remain unknown, were identified on the canine
sequence assembly (Figure 2, Appendix 2). On average, these
identified homologous canine segments were 83% of the size
TABLE 2. ESTS AND MARKERS MAPPED PER CHROMOSOME.
CFA size,
MB
blocks
number
RH markers
uniquely
mapped
ESTs
uniquely
mapped
ESTs
linked
EST/MB
RH panel
ESTs
database
EST/MB
database
1 137 4 135 34 1 0.26 895 6.53
2 99 2 90 20 0 0.20 733 7.40
3 105 4 85 18 4 0.21 580 5.52
4 100 2 93 16 0 0.16 578 5.78
5 99 3 108 26 0 0.26 599 6.05
6 87 2 79 16 1 0.20 462 5.31
7 94 4 114 15 0 0.16 673 7.16
8 86 1 76 13 3 0.19 689 8.01
9 77 4 95 16 3 0.25 522 6.78
10 80 3 60 15 3 0.23 702 8.78
11 86 1 96 14 2 0.19 592 6.88
12 85 2 113 20 1 0.25 564 6.64
13 75 1 54 8 1 0.12 331 4.41
14 72 1 75 9 1 0.14 559 7.76
15 75 1 76 16 0 0.21 497 6.63
16 73 3 64 18 2 0.27 368 5.04
17 80 2 80 17 1 0.23 435 5.44
18 66 1 79 16 1 0.26 543 8.23
19 66 3 57 4 0 0.06 212 3.21
20 66 1 93 13 5 0.27 507 7.68
21 61 4 86 8 1 0.15 408 6.69
22 61 1 53 7 6 0.21 393 6.44
23 61 1 51 7 2 0.15 318 5.21
24 73 1 51 16 0 0.22 369 5.05
25 60 2 68 14 1 0.25 451 7.52
26 48 1 50 9 1 0.21 389 8.10
27 57 1 67 15 1 0.28 532 9.33
28 55 1 53 19 1 0.36 310 5.64
29 51 1 53 8 0 0.16 313 6.14
30 47 2 42 15 2 0.36 415 8.83
31 50 2 34 8 2 0.20 265 5.30
32 51 1 29 3 0 0.06 447 8.76
33 41 1 39 11 0 0.27 215 5.24
34 50 1 41 6 1 0.14 221 4.42
35 38 1 24 5 0 0.13 187 4.92
36 41 1 44 4 1 0.12 220 5.37
37 40 1 47 6 0 0.15 214 5.35
38 38 2 24 5 0 0.13 149 3.92
X 139 3 52 8 0 0.06 927 6.67
Y 27 2 9 3 0 0.11 N/A N/A
Each chromosome was mapped in individual linkage groups (blocks, column 3) containing previously mapped markers (column
4, reference [12]), ESTs mapped in unique positions (column 5), and ESTs linked, but not ordered on the chromosome (column
6). The number of RH-mapped ESTs per MB for each chromosome (column 7) was compared to the number of all ESTs currently
in the database for each chromosome (column 8) per MB (column 9) to assess distribution of retinal expressed genes throughout
the genome.
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CFAof the corresponding human genome sequence interval, while
the interval homologous to CORS2 (HSA11p12-q13.3) was
covered by only 49%. The latter is likely because it spans the
HSA11 centromere. Candidate ESTs were identified for these
locations  based  on  their  positional  annotation  to  identify
potential candidate genes for the respective disorders. For
only one locus, X-chromosomal RP24, no potential candidate
clones mapped to the proposed homologous disease interval.
For twenty of these comparative genome regions in the dog,
which  include  clones  placed  on  the  presented  RH  maps
(Appendix 2, shaded), the respective diseases intervals are
also illustrated on the canine chromosome maps (Appendix
5).
DISCUSSION
Comparison of mapping approaches: EST clones from the
previously published canine retinal library [9] were re-aligned
against RefSeq sequences, with a criterion cut-off value of
E≤1e−3  accepted  as  establishing  homology.  This  yielded
annotation for 80% of clones evaluated. In the present study,
hypothesizing  that  the  remaining,  unidentified  sequences
might  represent  previously  unrecognized  retinal  genes  or
control elements relevant to retinal function, 553 such retinal
clones  were  mapped  to  the  RHDF5000–2  panel  with  high
confidence, and of these, 501 were mapped to unique positions
(Table 1, Figure 1, and Appendix 3). The resulting RH map
thus integrated these ESTs into the overall canine genome.
Among the mapped ESTs, 159 sequences (29%) aligned to
known  RefSeq  sequences,  but  the  balance  (71%;  394)
remained unidentified.
Direct  comparison  of  this  integrated  RH  map  to  the
assembled canine genome sequence became possible during
the progress of the present project. This permitted independent
confirmation of the location of mapped clones, comparative
evaluation  of  the  different  mapping  methods,  and,  as  a
consequence,  overcame  some  of  the  limitations  of  each
method. RH mapping is relatively unreliable toward the end
of linkage groups, and does not provide highly reliable order
for markers located close together. However, some of these
problems have recently been addressed in a refined map for
this panel [14]. Nonetheless, mapping of markers by sequence
alignment is subject to errors in assembly of the underlying
sequence. For example, gene duplications, pseudo genes, and
other sequence similarities within a single genome can create
both  ambiguities  in  assembly,  and  multiple  significant
alignments for a single marker; this was recognized in 4% of
the  presented  data.  Furthermore,  alignment  of  expressed
sequences, which may be spliced, against a genome assembly,
can  be  problematic  since  the  spliced  out  sequence  (e.g.,
introns) can cause difficulties in evaluating alignment scores.
The greater part of inconsistencies between placement on
the RH and sequence maps were minor. These were more
Figure  2.  Identification  of  potential
candidate  genes  for  human  retinal
disease  Human  genomic  intervals  for
known  diseases  (e.g.,  CORD9  on
HSA8, RP22 on HSA16) were mapped
against the canine genome to identify
homologous  regions,  and  EST  within
these  regions  of  interest  (e.g.,
DR010016B20F06  on  CFA16,
DR010020A10A07  on  CFA6).  A
comprehensive  list  of  these  disorders
and the number of corresponding ESTs
contained within our library is given in
Appendix  2.  ESTs  mapped  in  the
presented research are also illustrated on
the  respective  chromosomes  in
Appendix 5. Details on all clones can be
obtained through a web database (DOG
EST  or  DOG  EST  Project)  to  obtain
insights into corresponding transcripts
(e.g.: 1. WRN, 2. SORT1). We suggest
that this tool provides new positional
candidate  genes  for  mapped  human
retinal disorders. This would allow for
the identification of mutations in genes
that are thus far unknown or have not yet
been linked to retinal disorders, after the
exclusion  of  conventional  candidate
genes.
Molecular Vision 2009; 15:927-936 <http://www.molvis.org/molvis/v15/a97> © 2009 Molecular Vision
932common at the ends of chromosomes rather than the middle.
In  particular,  the  multiple  sequence  alignments  for  ESTs
mapping near the centromere of CFA11 and parts of CFA17
suggest sequence or assembly problems, or even potential
genome  duplications.  In  general,  major  disagreements
between the compared maps were rare and resulted in only
1%  of  the  chromosomal  placement  of  ESTs  to  remain
unresolved. While the data indicate room for improvement,
these issues are likely to be resolved with the improvement of
both  RH  maps  and  genome  sequence  assemblies.  The
synergistic  combination  of  different  approaches  provides
higher fidelity genome maps than does any single method
alone [15].
Genomic  coverage  of  retinal  ESTs:  Overall,  retinal  ESTs
analyzed in the current study do not appear to be concentrated
in particular areas of the genome, but were distributed rather
evenly throughout. There were, however, some departures
from this general observation. CFA19, CFA32, and CFAX
were  relatively  underrepresented  by  ESTs  mapped  in  the
present  study,  but  only  CFA19  showed  the  same
underrepresentation when adjusted for all ESTs from the same
library (Table 2). This suggests that the initial annotations
were more efficient for CFA32 and CFAX and, thus, fewer
clones were selected for additional mapping and annotation.
For CFA19, however, in addition to a lower representation of
retinal EST clones, one of the four ESTs RH-mapped to this
chromosome aligned to a different chromosome (CFA27) in
the canine genome sequence assembly, indicating a potential
error in one or the other map.
We attempted to identify canine ESTs that potentially
might represent novel candidate sequences for 28 mapped loci
for hereditary human retinal disorders. Surprisingly, the only
such locus that did not yield canine retinal ESTs contained
neither in the complete EST library nor was presented in the
RH  mapped  subset,  was  X-linked.  This  is  especially
remarkable  considering  the  well  recognized  strong
conservation of the mammalian X chromosome [16,17]. More
importantly,  all  three  ESTs  mapped  to  CFAY  on  the
RHDF5000–2 panel aligned close to the centromere of CFAX
based on sequence homology. Based on the absence of CFAY
sequences  from  the  CanFam2  assembly,  the  correct
assignment of the RH map linkage group to this chromosome
cannot be verified by sequence alignments. One therefore is
left to hypothesize whether this finding represent incorrect
linkage in the RH map or functional transcripts are indeed
encoded  on  CFAY.  However,  since  the  genomic  CFAX
sequence aligning to one of the clones, DR010006B10E05,
contained a microsatellite that is not present in the EST, it is
possible these transcripts have become inactivated on CFAX
but are still functionally present on CFAY. Further studies will
be  necessary  to  confirm  and  interpret  this  potentially
interesting finding.
Candidate  genes  for  human  retinal  disorders:  Despite
considerable progress in recent years, there has been a steady
gap between identification of the mapped loci for heritable
human  retinal  disorders,  and  characterization  of  the
underlying gene and causative mutations (D graph). In part,
this reflects an incomplete understanding of the genes critical
for  retinal  development,  function,  and  maintenance.
Currently, 48 such loci are recognized for which no causative
sequence change has been defined. For 20 loci, the candidate
region is either not precisely defined or extends over more
than  25  Mb.  For  the  remaining  28  loci,  we  attempted  to
identify retina-expressed ESTs that might represent potential
candidate genes, and were able to do so for all except the
aforementioned  X-linked  RP24  locus.  It  should  be
acknowledged that some of these clones may be redundant—
i.e., more than one EST might represent the same transcript.
Thus, the number of potential retinal expressed candidate
genes could be overestimated in our data set. Furthermore,
genomic regions for some human disease loci also do not align
unambiguously between human and dog, (e.g., MRST aligned
to several areas on CFA3 and CFA30), and, consequently, we
may  not  have  covered  the  complete  homologous  disease
intervals in the dog.
Confidence  in  the  RH  map  location  of  an  EST,  and,
concomitantly in its potential as a positional candidate, is
strengthened when confirmed by sequence alignment with the
corresponding genomic interval. This was achieved for the
majority of ESTs (93.6%) in the current study. However, three
clones potentially located within disease relevant areas were
mapped to different genomic locations with the RH map when
compared  to  the  genomic  sequence.  DR010007A10C09,
which aligns within the MRST homologous interval on CFA3
in the sequence assembly, was mapped with high confidence
to CFA4 on the RH map (Appendix 5, CFA4, C). In contrast,
DR010030A10D12 was located within the CORD9 interval
on CFA16 in the RH map, but showed sequence homology
just outside this interval in the sequence assembly; the same
applies to DR010030A10G12 in the RP23 interval on CFAX.
Despite these minor inconsistencies, however, homologous
canine intervals have successfully been established for most
of the human loci extracted from RetNet (Figure 2, Appendix
2).
The importance of correctly assigned location and tissue
specificity of potential disease candidate genes has recently
been  demonstrated  for  progressive  rod-cone  degeneration
(prcd) in the canine model. This disorder had previously been
mapped to CFA9, and known retinal expressed genes within
the disease critical interval had been excluded from causative
association with disease [18-20]. Once the EST library was
screened for positional candidates, transcripts expressing a
novel gene were identified harboring the mutation responsible
for prcd [21]. Subsequently, the gene was found to also cause
RP in humans. It should be remarked that this effort was
initially  complicated  by  the  fact  that  the  disease  critical
interval was incorrectly assembled to CFA18 in the first pass
of  the  canine  genome  assembly  CanFam1.  However,  the
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agreement with the presented RH mapping data.
A major advantage of comparative genomics lies in the
validation of results and preliminary data in the absence of
large patient cohorts to repeat or further narrow linkage data
of known disease loci. One of the most recent genes identified
to contribute to vision loss in humans is PROM1 [22]. A
missense mutation in the gene has been linked to formerly
mapped loci MCDR2 and STGD4 in a screen of 12 positional
candidate  genes  within  the  minimal  overlapping  disease
interval  of  12cM  between  markers  D4S1582  and
GATA1582G03.  This  region  corresponds  to  9.7  Mb  (bp
65,599,776 −71,744,479; 90,673,048–94,195,452) located on
CFA3 in the dog. The presented library contains 10 transcripts
for this genomic location; the most abundant one of those,
eight clones comprising contig 1265, represents the canine
version of PROM1. Thus, a cross species comparison may
have been able to assist in the ranking of candidate genes for
this  disease.  With  the  high  fidelity  of  genomic  location
established,  this  resource  is  well  suited  to  assist  with  the
investigation of known and new disease loci to speed up first
steps  in  the  identification  and  understanding  of  retinal
disorders.
In conclusion, a comparative map of retinal genes allows
identification of new candidate genes for retinal disorders in
both dog and human, and provides a further step toward the
complete  categorization  of  genes  relevant  to  retinal
development  and  degeneration.  Results  of  this  study  are
integrated into the web database at DOG EST or DOG EST
Project, and are publically accessible.
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Appendix 1.
To access the data, click or select the words “Appendix
1.” This will initiate the download of a (pdf) archive that
contains the file. Amplification details and results (F=PCR
failed, D=amplified from dog genomic DNA, RH=amplified
on the RH panel, M=placed on the final map) for all ESTs
tested.Appendix 2.
To access the data, click or select the words “Appendix
2.” This will initiate the download of a (pdf) archive that
contains the file. Human retinal disease loci mapped against
the canine genome. Based on the corresponding intervals,
potential candidate genes were identified from the canine
retinal EST library. The number of those ESTs is provided in
the last column (EST contained in the complete database/
subset al.so included in the currently presented RH mapping
project). Genomic regions containing ESTs mapped in the
present study (shaded) are also illustrated in Appendix 5.
Appendix 3.
To access the data, click or select the words “Appendix
3.” This will initiate the download of a (pdf) archive that
contains the file. Chromosomal location of each EST was
assigned using the MultiMap [13] best-two points function
using the previously published canine RH map [12]. Results
are listed for each EST to demonstrate linkage to the closest
marker (A) or indicate that the EST has collapsed with one of
the markers and been placed in the same genomic location
(B).
Appendix 4.
To access the data, click or select the words “Appendix
4.” This will initiate the download of a (pdf) archive that
contains the file. Markers were grouped into chromosomes
according to results of the best-two points function (Appendix
3) and subsequently mapped within each chromosome using
MultiMap [13]. Chromosomes for which marker density was
too  low  to  yield  a   consistent   whole-chromosome  linkage 
group were petitioned into blocks, and individual maps  were 
created  of  each  block.  Final  orientation  and location of all 
markers on the  chromosome  are  displayed  according  to 
previously   established    chromosome    orientation   [12].
Appendix  lists  all  markers  used  for  mapping,  selected 
markers  and  EST locations  are   graphically  displayed  in 
Appendix 5.
Appendix 5. Comparative maps of retinal expressed clones in the canine
genome.
To access the data, click or select the words “Appendix
5.” This will initiate the download of a (pdf) archive that
contains the file. Results of the EST mapping are graphically
displayed  for  each  chromosome  indicating  the  relative
position (A) of all mapped ESTs (B, blue) on the RH panel
(C), the corresponding chromosome sequence draft (D), and
potential alignments to nonhomologous chromosomes (E).
Placement is indicated by horizontal lines, while oblique lines
connect  placements  on  different  maps  for  the  same  EST.
Chromosomes are oriented with centromeres located next to
the respective legend on top of each page (A, 0); the artificial
scale  to  the  left  (A)  is  proportional  to  the  respective
chromosome size based on the RH mapping. For orientation,
selected markers are displayed on the RH map (B, red), and
marker groups mapped in individual blocks are separated by
black  lines.  ESTs  linked,  but  not  uniquely  mapped  to
individual  chromosome  are  displayed  in  italic.  Intervals
corresponding to mapped human disease loci (Appendix 2)
are indicated on the right of each homologous region of the
sequence drafts (C).
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